Dr. Hazel Szeto's discovery of a first-in-class compound that had mitochondrial therapeutic potential is now a U.S. Food and Drug Administration-approved drug.
Back to News
Weill Cornell MedicineOffice of External Affairs Phone: (646) 962-9476
